| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 67 |
| 1 | LIOTHYRONINE SODIUM | 37 |
| 2 | THYROID, PORCINE | 31 |
| 3 | ALEMTUZUMAB | 15 |
| 4 | LEVOTHYROXINE SODIUM ANHYDROUS | 14 |
| 5 | ERGOCALCIFEROL | 13 |
| 6 | DEXAMETHASONE | 12 |
| 7 | DEXAMETHASONE 1.5 MG | 12 |
| 8 | METHIMAZOLE | 10 |
| 9 | ACETAMINOPHEN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIOTHYRONINE SODIUM | 37 | 0.0042 |
| 1 | THYROID, PORCINE | 31 | 0.0029 |
| 2 | PROPYLTHIOURACIL | 4 | 0.0019 |
| 3 | METHIMAZOLE | 10 | 0.0013 |
| 4 | TEPROTUMUMAB | 6 | 0.0010 |
| 5 | ALEMTUZUMAB | 15 | 0.0008 |
| 6 | ERGOCALCIFEROL | 13 | 0.0004 |
| 7 | AMIODARONE HYDROCHLORIDE | 4 | 0.0004 |
| 8 | ICOSAPENT ETHYL | 3 | 0.0003 |
| 9 | LEVOTHYROXINE SODIUM | 67 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 1 | Corticosteroid [EPC] | 26 |
| 2 | Benzodiazepine [EPC] | 20 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 15 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 14 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 |
| 6 | Provitamin D2 Compound [EPC] | 13 |
| 7 | Estrogen [EPC] | 12 |
| 8 | Factor Xa Inhibitor [EPC] | 10 |
| 9 | Loop Diuretic [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 14 | 0.0014 |
| 1 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 6 | 0.0010 |
| 2 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 15 | 0.0008 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 6 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 7 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 8 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Antiseptic [EPC] | 1 | 0.0002 |